SituGen is a medical device startup that has developed a comprehensive system for extracting stem-cell-rich umbilical cord blood. The companys patented SG1040 is a disposable, all-inclusive, non-contaminating collection kit designed to increase the quality of cord blood and the number of stem cells extracted. The novel device is needle-free, preventing the bottleneck effect associated with needles. SituGen is an Israel-based company and part of the Rad-Bynet Group of multinational technology companies.